SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,798.97 -36.81
( -0.05%)

Global Indices

Nasdaq

52,223.83 255.58
(0.49%)

Dow Jones

7,434.43 1.45
(0.02%)

Hang Seng

62,158.55 -2,772.64
(-4.27%)

Nikkei 225

10,802.25 66.02
(0.61%)

Forex

USD-INR

96.67 0.19
(0.20%)

EUR-INR

110.18 0.12
(0.10%)

GBP-INR

129.04 -0.01
(0.00%)

JPY-INR

0.59 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

34.38

849.63

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.07

Back

reliance infrastructure ltd

Suraj consolidated net profit rises 31.02% in the June 2026 quarter

Jul 23,2026

Net profit of Suraj rose 31.02% to Rs 3.59 crore in the quarter ended June 2026 as against Rs 2.74 crore during the previous quarter ended June 2025. Sales declined 22.47% to Rs 39.03 crore in the quarter ended June 2026 as against Rs 50.34 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	39.03	50.34	-22
OPM %	16.47	9.61	-
PBDT	6.52	6.20	5
PBT	5.13	3.37	52
NP	3.59	2.74	31

76,798.97 -36.81 ( -0.05%)

52,223.83 255.58 (0.49%)

7,434.43 1.45 (0.02%)

62,158.55 -2,772.64 (-4.27%)

10,802.25 66.02 (0.61%)

96.67 0.19 (0.20%)

110.18 0.12 (0.10%)

129.04 -0.01 (0.00%)

0.59 0.00 (-0.04%)